Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Preoperative molecular testing in thyroid nodules with Bethesda VI cytology: Clinical experience and review of the literature.

Diagnostic cytopathology - 1 Apr 2021

Labourier Emmanuel, Fahey Thomas J

Abstract excerpt

Risk assessment is critical to determine the timing of elective surgeries and preserve valuable resources in time of pandemic. This study was undertaken to better understand the potential value of molecular testing to risk-stratify thyroid nodules with malignant cytology (Bethesda VI). Systematic review of the literature contributed 21 studies representing 2036 preoperative specimens. The BRAF p.V600E...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Gene Rearrangement
Share to MicroRNAs

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Proto-Oncogene Proteins B-raf

Share to Proto-Oncogene Proteins c-ret

Share to Receptor, trkA

Share to Telomerase

Share to Thyroid Nodule

Source

Open in PubMed Open full text

Identifiers

PMID: 33052631
DOI: 10.1002/dc.24637
PMCID: PMC7983887

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Preoperative molecular testing in thyroid nodules with Bethesda VI cytology: Clinical experience and review of the literature.PMID 33052631Read ↗

Molecular Profiling for Bethesda III to VI Nodules: Results of a Multicenter International Retrospective Study.Semantic proximity Read ↗

The actual and future role of molecular tests in thyroid pathology.Semantic proximity Read ↗

Current State of Molecular Cytology in Thyroid Nodules: Platforms and their Diagnostic and Theranostic UtilitySemantic proximity Read ↗

Molecular Profiling of 50 734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized Management.Semantic proximity Read ↗

Clinical use of Molecular Data in Thyroid Nodules and CancerSemantic proximity Read ↗

Clinical utility of a microRNA classifier in cytologically indeterminate thyroid nodules with RAS mutations: A multi-institutional study.Semantic proximity Read ↗

RAS mutation and associated risk of malignancy in the thyroid gland: An FNA study with cytology-histology correlation.Semantic proximity Read ↗

Association of Bethesda category and molecular mutation in patients undergoing thyroidectomySemantic proximity Read ↗

The 2023 Bethesda System Predicts Aggressive Features and Histologic Subtype in Thyroid CancerSemantic proximity Read ↗

How genetics changed or will change the therapy in thyroid nodules with indeterminate cytology?Semantic proximity Read ↗

Molecular profiling of thyroid nodules on cytologic samples: Findings from an Italian multi-institutional cohort.Semantic proximity Read ↗

Real-life utility of five-gene panel test in preoperative thyroid fine-needle aspiration biopsy: a large cohort of 740 patients study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.